Finding 75481 (2022-001)

Significant Deficiency
Requirement
P
Questioned Costs
-
Year
2022
Accepted
2023-03-27
Audit: 66134
Auditor: Kpmg LLP

AI Summary

  • Core Issue: Inaccurate reporting of federal expenditures on the Schedule of Expenditures of Federal Awards (SEFA) due to reliance on payment dates instead of service dates.
  • Impacted Requirements: Non-compliance with 2 CFR 200.510(b) and 2 CFR 200.303 regarding accurate financial reporting and internal controls.
  • Recommended Follow-Up: Implement stronger internal controls to ensure accurate reporting for the HRSA COVID-19 Uninsured Program on the SEFA.

Finding Text

Finding No. 2022-001 Federal Agency: U.S. Department of Health and Human Services Program Name: HRSA COVID-19 Claims Reimbursement for the Uninsured Program and the COVID-19 Coverage Assistance Fund Assistance Listing Number: 93.461 Federal Award Year: July 1, 2021 ? June 30, 2022 Compliance Requirements: Other ? Inaccurate reporting of the Schedule of Expenditures of Federal Awards Criteria According to 2 CFR 200.510(b), a recipient of federal awards is required to prepare a Schedule of Expenditures of Federal Awards (SEFA) for the period covered by the entity?s financial statements which must include the total Federal awards expended as determined in accordance with 2 CFR 200.502. Additionally, 2 CFR 200.303 requires non-Federal entities receiving Federal awards to establish and maintain internal controls designed to reasonably ensure compliance with Federal laws, regulations, and program compliance requirements. Effective internal controls should include procedures to ensure federal expenditures are accurately reported on the SEFA and information provided for audit purposes is complete and accurate. Conditions Found Lehigh Valley Health Network and Subsidiaries (the ?Organization?) did not have adequate controls relating to the reporting of expenditures for the HRSA COVID-19 Claims Reimbursement for the Uninsured Program and the COVID-19 Coverage Assistance Fund (the ?Uninsured Program?) in the SEFA. Specifically, the amounts originally provided on the SEFA for the year ended June 30, 2022 for the Uninsured Program were based on when claim payments were received rather than when the services were provided for claim reimbursement. Once the error was identified, management corrected the SEFA for the year ended June 30, 2022 to reflect the total amount of claims for services provided during the year ended June 30, 2022 for the Uninsured Program. Cause and Effect In discussing these conditions with management, they stated that sufficient controls were not in place to ensure that the date of the patient service or treatment was used to determine the appropriate amounts and year to include the payment received from HRSA on the SEFA. Failure to establish effective internal controls regarding financial reporting for the preparation of the SEFA may prevent the Organization from completing an audit in accordance with 2 CFR Part 200. Questioned Costs There are no questioned costs related to this finding. Statistical Sample Not applicable. Repeat Finding A similar finding was not reported in the prior year audit. Recommendation We recommend the Organization establish internal controls to ensure the HRSA COVID-19 Uninsured Program is accurately reported on the SEFA and information provided for audit purposes is complete and accurate. View of Responsible Officials Since the inception of the program, the Organization reported the HRSA COVID-19 for the Uninsured based on payment date rather than on date of service/ incurred date. Once the error was identified, management properly reported and corrected the SEFA for the year ended June 30, 2022 to reflect the total amount of claims for services provided during the year ended June 30, 2022 for the Uninsured Program.

Categories

Reporting

Other Findings in this Audit

  • 75476 2022-001
    Significant Deficiency
  • 75477 2022-001
    Significant Deficiency
  • 75478 2022-001
    Significant Deficiency
  • 75479 2022-001
    Significant Deficiency
  • 75480 2022-001
    Significant Deficiency
  • 75482 2022-001
    Significant Deficiency
  • 75483 2022-001
    Significant Deficiency
  • 75484 2022-001
    Significant Deficiency
  • 75485 2022-001
    Significant Deficiency
  • 75486 2022-001
    Significant Deficiency
  • 651918 2022-001
    Significant Deficiency
  • 651919 2022-001
    Significant Deficiency
  • 651920 2022-001
    Significant Deficiency
  • 651921 2022-001
    Significant Deficiency
  • 651922 2022-001
    Significant Deficiency
  • 651923 2022-001
    Significant Deficiency
  • 651924 2022-001
    Significant Deficiency
  • 651925 2022-001
    Significant Deficiency
  • 651926 2022-001
    Significant Deficiency
  • 651927 2022-001
    Significant Deficiency
  • 651928 2022-001
    Significant Deficiency

Programs in Audit

ALN Program Name Expenditures
93.498 Provider Relief Fund $37.09M
84.268 Federal Direct Student Loans $510,631
97.036 Disaster Grants - Public Assistance (presidentially Declared Disasters) $501,992
93.155 Rural Health Research Centers $327,570
84.425 Education Stabilization Fund $313,559
93.399 Cancer Control $284,900
93.575 Child Care and Development Block Grant $190,491
93.870 Maternal, Infant and Early Childhood Home Visiting Grant $126,360
84.063 Federal Pell Grant Program $118,478
21.027 Coronavirus State and Local Fiscal Recovery Funds $88,329
93.788 Opioid Str $51,458
93.243 Substance Abuse and Mental Health Services_projects of Regional and National Significance $17,798
16.575 Crime Victim Assistance $17,552
93.080 Blood Disorder Program: Prevention, Surveillance, and Research $15,500
93.395 Cancer Treatment Research $14,000
93.870 Covid-19 Maternal, Infant and Early Childhood Home Visiting Grant $13,455
93.461 Covid-19 Testing for the Uninsured $8,509
93.110 Maternal and Child Health Federal Consolidated Programs $7,500
93.924 Ryan White Hiv/aids Dental Reimbursement and Community Based Dental Partnership Grants $6,094
93.360 Biomedical Advanced Research and Development Authority (barda), Biodefense Medical Countermeasure Development $5,620
93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders $4,170
10.555 National School Lunch Program $3,824
93.866 Aging Research $3,420
93.889 Covid-19 National Bioterrorism Hospital Preparedness Program $1,442
93.279 Drug Abuse and Addiction Research Programs $300